ConductScience.org, home

Library / Trials

ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement

NCT01573546, Not applicable, Completed, Duke University

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancementClinicalTrials.gov
NCT numberNCT01573546ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment160 participants, actualClinicalTrials.gov
Lead sponsorDuke UniversityClinicalTrials.gov
ConditionsCognitive Impairment, no Dementia (CIND)ClinicalTrials.gov
InterventionsAerobic Exercise, DASH diet, Health education controlClinicalTrials.gov
First posted2012-04-09ClinicalTrials.gov
Last updated2018-04-18ClinicalTrials.gov

Registered outcomes 11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange in Executive FunctionBaseline to post-treatment assessment at 6 monthsComposite executive function measure includes Trail Making Test, Stroop Test, Digit Span, Digit Symbol Substitution Test, Ruff 2 \& 7 Test, and Animal Naming TestClinicalTrials.gov
SecondaryChange in Memory6 monthsSecondary outcomes will include composite measures of memory (Hopkins Verbal Learning Test-Revised and Medical College of Georgia Complex Figure Test)ClinicalTrials.gov
SecondaryChange in Language6 monthsSecondary outcomes will include composite measures of language (Controlled Oral Word Association Test and Animal Naming Test)ClinicalTrials.gov
SecondaryInflammation6 monthsWe will also assess treatment effects on measures of inflammation, including C-reactive protein and interleukin-6.ClinicalTrials.gov
SecondaryFunctional Capacity6 monthsFunctional capacity (6MWT and peak VO2). Six-minute walk distance (6MWT) and peak VO2 from a treadmill test will be assessed by an exercise physiologist.ClinicalTrials.gov
SecondaryBlood Pressure6 monthsWe also will examine treatment effects on the vascular function measures, including blood pressure.ClinicalTrials.gov
SecondaryFlow-mediated dilation of the brachial artery6 monthsWe also will examine treatment effects on the vascular function measures, including flow-mediated dilation of the brachial artery.ClinicalTrials.gov
SecondaryArterial Stiffness6 monthsWe also will examine treatment effects on the vascular function measures, including pulse-wave velocity of the femoral artery.ClinicalTrials.gov
SecondaryIntima-medial thickness6 monthsWe also will examine treatment effects on the vascular function measures, including intima-medial thickness of the carotid artery.ClinicalTrials.gov
SecondaryFasting glucose6 monthsWe will also assess treatment effects on measures fasting glucoseClinicalTrials.gov
SecondaryCholesterol6 monthsWe will also examine treatment effects on cholesterol, including LDL, HDL, and total cholesterolClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
23000080BACKGROUNDPubMed
28437380DERIVEDPubMed
30568005DERIVEDPubMed
31755550DERIVEDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 9

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Category FluencyPrimary outcomeConductCognition
Digit Span TestPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition
Symbol CodingPrimary outcomeConductCognition
Trail Making Test APrimary outcomeConductCognition
Trail Making Test BPrimary outcomeConductCognition
Complex Figure Copy and RecallSecondary outcomeConductCognition
Verbal FluencySecondary outcomeConductCognition
Verbal LearningSecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)